Catering to wide requirements of clients since years, we have been successfully engaged in exporting an excellent stock of Erlonat 150 (Erlotinib Tablet). The medicine is offered in excellent packing to clients at feasible prices. The medication is indicated for maintenance treatment, 1st-line treatment and 2nd- or 3rd-line treatment for advanced-stage non-small cell lung cancer (NSCLC). In addition, Erlonat 150 (Erlotinib Tablet) is also clinically approved for advanced-stage pancreatic cancer.
It belongs to a specific class of medicines called kinase inhibitors
It blocks action of an abnormal protein that signals cancer cells to multiply